SCHEMBL6681808

SCHEMBL6681808

Oc1cccc(C2(O)CCNCC2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.50
OPRD1 P41143 2/20 0.44
OPRM1 P35372 5/20 0.43
SIGMAR1 Q99720 1/20 0.40
CA12 O43570 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.39
CA5A P35218 1/20 0.39
CA9 Q16790 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
OPRK1 P41145 2/20 0.38
MEN1 O00255 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
KMT2A Q03164 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31690834 0.98 DRD2 (0.49) DRD2OPRD1OPRM1SIGMAR1CA12
SCHEMBL3946783 0.81 OPRM1 (0.47) OPRD1OPRM1CA12ALDH1A1CA2
SCHEMBL2270948 0.80 OPRM1 (0.52) DRD2OPRD1OPRM1SIGMAR1OPRK1
SCHEMBL6041772 0.80 DRD2 (0.49) DRD2OPRD1OPRM1SIGMAR1ALDH1A1
SCHEMBL3153964 0.80 OPRM1 (0.52) DRD2OPRD1OPRM1ALDH1A1OPRK1
SCHEMBL23660784 0.80 OPRD1 (0.42) OPRD1OPRM1
SCHEMBL652461 0.80 DRD2 (0.62) DRD2OPRD1OPRM1SIGMAR1CYP3A4
SCHEMBL6601890 0.80 OPRD1 (0.63) OPRD1OPRM1OPRK1
SCHEMBL3084744 0.80 OPRM1 (0.43) OPRD1OPRM1OPRK1MEN1SLC6A2
Hydrochloric Acid SCHEMBL2585702 0.79 OPRD1 (0.41) DRD2OPRD1OPRM1CA12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117447388-A Preparation and application of deuterated 4-phenylpiperidine-4-alcohol compound 南昌双天使生物科技开发有限公司 2024-01-26 CN disclosed
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-05-12 US disclosed
WO-2020186220-A1 COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR IMMUNOPHAGE BIOMEDICAL CO., LTD. (CN) 2020-09-17 WO disclosed
EP-1097924-B1 4-hydroxy-4-phenylpiperidine derivatives having opioid agonist activity and pharmaceuticals containing the same SSP CO LTD (JP) 2004-08-25 EP disclosed
US-6362203-B1 ANALGESICS SSP CO., LTD (JP) 2002-03-26 US disclosed
CN-1304929-A 4-hydroxy-4-phenyl piperidine derivative and medicine containing said derivative SS PHARMACEUTICAL CO (JP) 2001-07-25 CN disclosed
EP-1097924-A1 4-hydroxy-4-phenylpiperidine derivatives having -opioid agonist activity and pharmaceuticals containing the same SSP Co., Ltd. (JP) 2001-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220144838-A1 Compounds as Inhibitors of Macrophage Migration Inhibitory Factor MIF, MMP12, SLC11A2 DRD2 4337/4885OPRD1 2755/4885OPRM1 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.